Agilent Technologies, Inc. (A)
A Price and Sentiment
A Latest news
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma2021-10-21 08:31
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and the fourth leading cause of cancer death worldwide, with over 1,000,000 new cases and approximately 770,000 deaths
The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold.
The S&P 500 Index wrapped up its best week since July, climbing 1.8% on encouraging quarterly earnings releases from several companies
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer2021-10-13 16:16
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC assay measuring Ki-67 expression to receive FDA approval in the context of treatment with Verzenio and was de
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Professor Bernhard Lendl has been selected to receive a prestigious Agilent Thought Leader Award. Highly renowned in the field of vibrational spectroscopy, Dr. Lendl is a professor at the TU Wien (Vienna) and head of the working group on Process Analysis & Vibrational Spectroscopy at the institution. Professor Lendl's work focuses on adapting powerful spectroscopic techniques and unique combinations of
A weekly summary of dividend activity for Dividend Champions and Contenders.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors.
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces dividend.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.